{
 "as_of": "2026-11-06",
 "cmr": "uk-cm-kg/AIM/OPTI",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# OPTIBIOTIX HEALTH PLC (AIM: OPTI) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nOPTIBIOTIX HEALTH PLC is listed on AIM under the ticker OPTI, with ISIN GB00BP0RTP38 and LEI 213800UKYQFT941QHS14. Its security type is Corporate, its segment is ASQ1, and its sector is Pharmaceuticals and Biotechnology [201030]. Its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 22 filings across 22 filing days in the twelve months to 2026-11-06. The median gap between filing days is 11 days. The latest filing is dated 2026-10-29, eight days before the record date, and is a regulatory announcement. The AIM exchange median is 33.5 filings, a cadence gap of 7.0 days and a latency of 4 days across 594 issuers. The sector median is 42 filings, a cadence gap of 6.0 days and a latency of 4.0 days across 51 issuers.\n\n## Auditor\n\nThe auditor of record is Gerald Edelman LLP. Its location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, because this register does not yet have a lifecycle type map. The halt flag is listed, not halted.\n\n## Orderability\n\nFor elective professional client, the outcome is signal ACM-200, determinable. For eligible counterparty, the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04.\n\n## Coverage\n\nNo research houses were named on the issuer's investor-relations page; none was found on the pages read. The count is 0.\n\n## Open research\n\nNo openly published research notes were found. The count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe sealed years in the store for this issuer are 2021, 2022, 2023, 2024, 2025 and 2026, but they are not served as of a date; the as-of door answers not_sealed. The market's vintage is not sealed, so no earliest sealed date is recorded. The live record began on 2026-09-11.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/OPTI (identity.isin)\n- https://find-and-update.company-information.service.gov.uk/company/05880755 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://www.londonstockexchange.com/stock/OPTI/optibiotix-health-plc/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/AIM/OPTI (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://find-and-update.company-information.service.gov.uk/company/05880755/filing-history/MzUyNzkyNjQ4M2FkaXF6a2N4/document?format=pdf&download=0 (the auditor)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.uk-cm-kg.ai/record/AIM/OPTI (the record)\n",
 "market": "UK",
 "node": "uk-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-11",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "read by ChatGPT (batch)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://find-and-update.company-information.service.gov.uk/company/05880755/filing-history/MzUyNzkyNjQ4M2FkaXF6a2N4/document?format=pdf&download=0",
    "state": "filled",
    "value": "Gerald Edelman LLP"
   },
   "auditor_firm_id": {
    "market": "UK",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "UK",
    "state": "not_on_record"
   },
   "changes": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "uk-cm-kg/AIM/OPTI",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 594,
     "median_cadence_gap_days": 7,
     "median_filings": 33.5,
     "median_latency_days": 4,
     "name": "AIM"
    },
    "sector": {
     "issuers": 51,
     "median_cadence_gap_days": 6,
     "median_filings": 42,
     "median_latency_days": 4,
     "name": "Pharmaceuticals and Biotechnology [201030]"
    }
   },
   "by_type": {
    "agm_record_date": 1,
    "ch_accounts_filed": 1,
    "ch_confirmation_statement": 1,
    "ch_resolution": 1,
    "corporate_action": 1,
    "director_dealing": 1,
    "early_warning": 2,
    "financial_statement": 2,
    "regulatory_announcement": 12
   },
   "cadence_median_gap_days": 11,
   "filing_days": 22,
   "filings": 22,
   "latency_days": 8,
   "latest": [
    {
     "category": null,
     "date": "2026-10-29",
     "source": "https://www.investegate.co.uk/announcement/rns/optibiotix-health--opti/release-of-video-updates-on-investor-hub/9846938",
     "title": "Release of Video Updates on Investor Hub",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-09-08",
     "source": "https://www.investegate.co.uk/announcement/rns/optibiotix-health--opti/sweetbiotix-update/9759785",
     "title": "SweetBiotix® Update",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-09-02",
     "source": "https://www.investegate.co.uk/announcement/rns/optibiotix-health--opti/h-b-launches-formi-product-containing-slimbiome-/9750551",
     "title": "H&B launches FORMI™ Product containing SlimBiome®",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-08-03",
     "source": "https://find-and-update.company-information.service.gov.uk/company/05880755/filing-history/MzUzNjcxMTExMGFkaXF6a2N4/document?format=pdf&download=0",
     "title": "confirmation statement with no updates — 2026-07-19",
     "type": "ch_confirmation_statement"
    },
    {
     "category": null,
     "date": "2026-07-15",
     "source": "https://find-and-update.company-information.service.gov.uk/company/05880755/filing-history/WUY1VEJTVTFhZGlxemtjeA/document?format=pdf&download=0",
     "title": "resolution",
     "type": "ch_resolution"
    }
   ],
   "latest_filing_date": "2026-10-29",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.uk-cm-kg.ai/events/AIM/OPTI",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "AIM"
   },
   "isin": {
    "read_by": "LSE instrument reference record (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/OPTI",
    "state": "confirmed",
    "value": "GB00BP0RTP38"
   },
   "jurisdiction": {
    "read_by": "Companies House REST API (company profile) (jurisdiction field)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://find-and-update.company-information.service.gov.uk/company/05880755",
    "state": "confirmed",
    "value": "England and Wales (Companies House jurisdiction field)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN GB00BP0RTP38)",
    "state": "sourced",
    "value": "213800UKYQFT941QHS14"
   },
   "name": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "OPTIBIOTIX HEALTH PLC"
   },
   "sector": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/OPTI/optibiotix-health-plc/company-page",
    "state": "sourced",
    "value": "Pharmaceuticals and Biotechnology [201030]"
   },
   "security_type": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "ASQ1"
   },
   "ticker": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "OPTI"
   },
   "website": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/OPTI/optibiotix-health-plc/company-page",
    "state": "sourced",
    "value": "www.optibiotix.com"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "UK",
  "node": "uk-cm-kg",
  "numbers_hash": "sha256:2c2fc14bdf9c25b1c26334588cd0209df46c434c0ee306d3a861c63336ad29eb",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "elective professional client",
    "eligible counterparty"
   ],
   "outcomes": {
    "elective professional client": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "eligible counterparty": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json",
    "door": "https://mcp.uk-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1",
   "section": "uk.aio.v16"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.uk-cm-kg.ai/record/AIM/OPTI",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://marketsecurities.fca.org.uk/officiallist",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:2c2fc14bdf9c25b1c26334588cd0209df46c434c0ee306d3a861c63336ad29eb",
 "path": "/uk/AIM/OPTI",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "OPTIBIOTIX HEALTH PLC is listed on AIM under the ticker OPTI, with ISIN GB00BP0RTP38 and LEI 213800UKYQFT941QHS14. Its security type is Corporate, its segment is ASQ1, and its sector is Pharmaceuticals and Biotechnology [201030]. Its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 22 filings across 22 filing days in the twelve months to 2026-11-06. The median gap between filing days is 11 days. The latest filing is dated 2026-10-29, eight days before the record date, and is a regulatory announcement. The AIM exchange median is 33.5 filings, a cadence gap of 7.0 days and a latency of 4 days across 594 issuers. The sector median is 42 filings, a cadence gap of 6.0 days and a latency of 4.0 days across 51 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is Gerald Edelman LLP. Its location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, because this register does not yet have a lifecycle type map. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For elective professional client, the outcome is signal ACM-200, determinable. For eligible counterparty, the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were named on the issuer's investor-relations page; none was found on the pages read. The count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found. The count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The sealed years in the store for this issuer are 2021, 2022, 2023, 2024, 2025 and 2026, but they are not served as of a date; the as-of door answers not_sealed. The market's vintage is not sealed, so no earliest sealed date is recorded. The live record began on 2026-09-11.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer"
  },
  {
   "for": "identity.isin",
   "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/OPTI"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://find-and-update.company-information.service.gov.uk/company/05880755"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "identity.sector",
   "source": "https://www.londonstockexchange.com/stock/OPTI/optibiotix-health-plc/company-page"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.uk-cm-kg.ai/events/AIM/OPTI"
  },
  {
   "for": "the halt flag",
   "source": "https://marketsecurities.fca.org.uk/officiallist"
  },
  {
   "for": "the auditor",
   "source": "https://find-and-update.company-information.service.gov.uk/company/05880755/filing-history/MzUyNzkyNjQ4M2FkaXF6a2N4/document?format=pdf&download=0"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.uk-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.uk-cm-kg.ai/record/AIM/OPTI"
  }
 ],
 "title": "OPTIBIOTIX HEALTH PLC (OPTI) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}